Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Scientific Reports
|
October 16, 2015
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology
|
April 2, 2019
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
Chen-Hua Liu, Yu-Lueng Shih, Sheng-Shun Yang, et al.
Immunity
|
October 19, 2017
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4<sup>+</sup> T Cells Permissive for Latent HIV-1 Infection
Liang Shan, Kai Deng, Hongbo Gao, et al.
Scientific Reports
|
September 14, 2018
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
Chen-Hua Liu, Yi-Jie Huang, Sien-Sing Yang, et al.
Liver Cancer
|
May 14, 2020
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
Tai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, et al.
JHEP Reports : Innovation in Hepatology
|
April 19, 2021
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
Su-Ru Lin, Ta-Yu Yang, Cheng-Yuan Peng, et al.
Scientific Reports
|
May 13, 2017
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
Tung-Hung Su, Chung-Wai Shiau, Ping Jao, et al.
Rheumatology (Oxford, England)
|
August 12, 2025
Non-negligible risk of HBV reactivation among rheumatoid arthritis patients receiving JAK inhibitors: bridging the evidence gap
Ting-Yuan Lan, Tai-Ju Lee, Ting-Wei Chang, et al.
Hepatology (Baltimore, Md.)
|
January 17, 2013
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
Ming-Lung Yu, Chuan-Mo Lee, Chi-Ling Chen, et al.
Annals of Internal Medicine
|
December 4, 2013
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Scientific Reports
|
October 16, 2015
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology
|
April 2, 2019
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
Chen-Hua Liu, Yu-Lueng Shih, Sheng-Shun Yang, et al.
Immunity
|
October 19, 2017
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4<sup>+</sup> T Cells Permissive for Latent HIV-1 Infection
Liang Shan, Kai Deng, Hongbo Gao, et al.
Scientific Reports
|
September 14, 2018
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
Chen-Hua Liu, Yi-Jie Huang, Sien-Sing Yang, et al.
Liver Cancer
|
May 14, 2020
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
Tai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, et al.
JHEP Reports : Innovation in Hepatology
|
April 19, 2021
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
Su-Ru Lin, Ta-Yu Yang, Cheng-Yuan Peng, et al.
Scientific Reports
|
May 13, 2017
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
Tung-Hung Su, Chung-Wai Shiau, Ping Jao, et al.
Rheumatology (Oxford, England)
|
August 12, 2025
Non-negligible risk of HBV reactivation among rheumatoid arthritis patients receiving JAK inhibitors: bridging the evidence gap
Ting-Yuan Lan, Tai-Ju Lee, Ting-Wei Chang, et al.
Hepatology (Baltimore, Md.)
|
January 17, 2013
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
Ming-Lung Yu, Chuan-Mo Lee, Chi-Ling Chen, et al.
Annals of Internal Medicine
|
December 4, 2013
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Page
of 15